Glimepiride 3mg + Metformin 1000mg Tablet in PCD pharma franchise in Hyderabad

Glimepiride 3mg + Metformin 1000mg Tablet in pharmaceutical manufacturing company in Mumbai

Glimepiride 3mg + Metformin 1000mg Tablet in antidiabetic pharma franchise in Pune

Glimepiride 3mg + Metformin 1000mg Tablet in pharma suppliers in Delhi

Glimepiride 3mg + Metformin 1000mg Tablet in pharma export companies in Kolkata
Glimepiride 3mg + Metformin 1000mg Tablet in pharma franchise opportunities in Bengaluru

Home/Products /glimepiride-i-point-p-point-3mg-metformin-1000mg-bi-layered-tablets

Gimtype M3 Forte Tablet

Composition : Glimepiride I.P. 3mg + Metformin Hydrochloride (S.R.) I.P. 1000mg Bi-Layered Tablets

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*15

Price : ₹229/-

Metfoam G3 Forte Tablet combines Glimepiride 3mg with sustained-release Metformin Hydrochloride 1000mg in a bi-layered tablet. This formulation provides a balanced approach to managing type 2 diabetes mellitus by stimulating insulin secretion and enhancing insulin sensitivity. The sustained-release layer ensures gradual absorption of Metformin, reducing gastrointestinal side effects while maintaining effective blood glucose control throughout the day.

Read More

About the Product

Metfoam G3 Forte Tablet combines Glimepiride 3mg with sustained-release Metformin Hydrochloride 1000mg in a bi-layered tablet. This formulation provides a balanced approach to managing type 2 diabetes mellitus by stimulating insulin secretion and enhancing insulin sensitivity. The sustained-release layer ensures gradual absorption of Metformin, reducing gastrointestinal side effects while maintaining effective blood glucose control throughout the day.

Possible side effects include hypoglycemia, nausea, abdominal discomfort, dizziness, and rare risk of lactic acidosis with Metformin.

Recommended for adults with type 2 diabetes who require both improved insulin secretion and better insulin action to achieve optimal glycemic control.

Take with meals to reduce gastrointestinal discomfort. Regular blood glucose and kidney function monitoring is advised. Not indicated for type 1 diabetes or diabetic ketoacidosis.

Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation